Indication: Bacterial Infection

An Open label, Dose-finding, Pharmacokinetics, Safety, and Tolerability Study of Oritavancin Single Dose Infusion in Pediatric Subjects Less Than 18 Years of Age with Suspected or Confirmed Bacterial Infections

Sub-indication: Bacterial Infection

Study Type: Drug Study

Principal Investigator: Janice Sullivan, M.D.
Norton Children's Critical Care, affiliated with the UofL School of Medicine

Sponsor: Sponsor: Melinta Therapeutics, Inc.

Learn more at ClinicalTrials.gov

Email for more information: NCRI-ID@NortonHealthcare.org

Search our entire site.